176 related articles for article (PubMed ID: 35263471)
21. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.
Meier A; Reiche D; de Laat M; Pollitt C; Walsh D; Sillence M
PLoS One; 2018; 13(9):e0203655. PubMed ID: 30212530
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
Donaldson MT; Jorgensen AJ; Beech J
J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
[TBL] [Abstract][Full Text] [Related]
23. Metabolic perturbations in Welsh Ponies with insulin dysregulation, obesity, and laminitis.
Jacob SI; Murray KJ; Rendahl AK; Geor RJ; Schultz NE; McCue ME
J Vet Intern Med; 2018 May; 32(3):1215-1233. PubMed ID: 29572947
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
25. Histopathology of insulin-induced laminitis in ponies.
Asplin KE; Patterson-Kane JC; Sillence MN; Pollitt CC; Mc Gowan CM
Equine Vet J; 2010 Nov; 42(8):700-6. PubMed ID: 21039799
[TBL] [Abstract][Full Text] [Related]
26. Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis.
Sillence M; Meier A; de Laat M; Klee R; Reiche D
BMC Vet Res; 2022 Jan; 18(1):49. PubMed ID: 35042535
[TBL] [Abstract][Full Text] [Related]
27. Obesity and obesity-associated metabolic disease conditions in Connemara ponies in Ireland.
Al-Ansari AS; Golding E; Walshe N; Mooney CT; Duggan V
Equine Vet J; 2024 Mar; 56(2):273-280. PubMed ID: 37985219
[TBL] [Abstract][Full Text] [Related]
28. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
Asplin KE; Sillence MN; Pollitt CC; McGowan CM
Vet J; 2007 Nov; 174(3):530-5. PubMed ID: 17719811
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia.
Morgan RA; McGowan TW; McGowan CM
Aust Vet J; 2014 Apr; 92(4):101-6. PubMed ID: 24673135
[TBL] [Abstract][Full Text] [Related]
30. Relationships between total adiponectin concentrations and obesity in native-breed ponies in England.
Barnabé MA; Elliott J; Harris PA; Menzies-Gow NJ
Equine Vet J; 2024 Mar; 56(2):264-272. PubMed ID: 37800870
[TBL] [Abstract][Full Text] [Related]
31. Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia.
Nourian AR; Asplin KE; McGowan CM; Sillence MN; Pollitt CC
Equine Vet J; 2009 Sep; 41(7):671-7. PubMed ID: 19927586
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
Wylie CE; Collins SN; Verheyen KL; Newton JR
Vet J; 2013 Oct; 198(1):57-69. PubMed ID: 24070987
[TBL] [Abstract][Full Text] [Related]
33. Seasonal and annual influence on insulin and cortisol results from overnight dexamethasone suppression tests in normal ponies and ponies predisposed to laminitis.
Borer-Weir KE; Menzies-Gow NJ; Bailey SR; Harris PA; Elliott J
Equine Vet J; 2013 Nov; 45(6):688-93. PubMed ID: 23521139
[TBL] [Abstract][Full Text] [Related]
34. Equine metabolic syndrome in UK native ponies and cobs is highly prevalent with modifiable risk factors.
Carslake HB; Pinchbeck GL; McGowan CM
Equine Vet J; 2021 Sep; 53(5):923-934. PubMed ID: 33128277
[TBL] [Abstract][Full Text] [Related]
35. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
Knowles EJ; Menzies-Gow NJ; Mair TS
Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
[TBL] [Abstract][Full Text] [Related]
36. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
[TBL] [Abstract][Full Text] [Related]
37. Effect of varying the dose of corn syrup on the insulin and glucose response to the oral sugar test.
Jocelyn NA; Harris PA; Menzies-Gow NJ
Equine Vet J; 2018 Nov; 50(6):836-841. PubMed ID: 29504630
[TBL] [Abstract][Full Text] [Related]
38. Short-term induced hyperinsulinaemia and dexamethasone challenge do not affect circulating total adiponectin concentrations in insulin-sensitive ponies.
Barnabé MA; Elliott J; Harris PA; Menzies-Gow NJ
Equine Vet J; 2024 Mar; 56(2):332-341. PubMed ID: 37800859
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
Karikoski NP; Horn I; McGowan TW; McGowan CM
Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
[TBL] [Abstract][Full Text] [Related]
40. Morphological and cellular changes in secondary epidermal laminae of horses with insulin-induced laminitis.
Karikoski NP; Patterson-Kane JC; Asplin KE; McGowan TW; McNutt M; Singer ER; McGowan CM
Am J Vet Res; 2014 Feb; 75(2):161-8. PubMed ID: 24471752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
